ArticleJournal of translational medicine2021

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy.

Xuanzong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.